Rep. April McClain Delaney Purchases Shares of Labcorp Holdings Inc. (NYSE:LH)

Representative April McClain Delaney (D-Maryland) recently bought shares of Labcorp Holdings Inc. (NYSE:LH). In a filing disclosed on December 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Labcorp stock on November 17th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Brown & Brown (NYSE:BRO) on 11/20/2025.
• Sold $1,001 – $15,000 in shares of EMCOR Group (NYSE:EME) on 11/17/2025.
• Sold $1,001 – $15,000 in shares of Quanta Services (NYSE:PWR) on 11/17/2025.
• Purchased $1,001 – $15,000 in shares of Markel Group (NYSE:MKL) on 11/3/2025.
• Sold $1,001 – $15,000 in shares of Teledyne Technologies (NYSE:TDY) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Fortune Brands Innovations (NYSE:FBIN) on 10/31/2025.
• Purchased $1,001 – $15,000 in shares of Brown & Brown (NYSE:BRO) on 10/31/2025.
• Purchased $1,001 – $15,000 in shares of Labcorp (NYSE:LH) on 10/31/2025.
• Purchased $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Fortune Brands Innovations (NYSE:FBIN) on 10/29/2025.

Labcorp Stock Performance

Shares of Labcorp stock opened at $257.90 on Wednesday. The company has a current ratio of 1.55, a quick ratio of 1.35 and a debt-to-equity ratio of 0.59. The firm has a market cap of $21.38 billion, a P/E ratio of 25.33, a P/E/G ratio of 1.72 and a beta of 0.99. The stock’s fifty day moving average price is $268.45 and its 200-day moving average price is $265.97. Labcorp Holdings Inc. has a 12 month low of $209.38 and a 12 month high of $293.72.

Labcorp (NYSE:LH) last announced its quarterly earnings results on Tuesday, October 28th. The medical research company reported $4.18 earnings per share for the quarter, topping the consensus estimate of $4.13 by $0.05. The firm had revenue of $3.56 billion during the quarter, compared to analysts’ expectations of $3.56 billion. Labcorp had a net margin of 6.21% and a return on equity of 15.85%. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.50 EPS. Labcorp has set its FY 2025 guidance at 16.150-16.500 EPS. On average, equities research analysts expect that Labcorp Holdings Inc. will post 16.01 earnings per share for the current fiscal year.

Labcorp Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 11th. Stockholders of record on Wednesday, November 26th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Wednesday, November 26th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 1.1%. Labcorp’s dividend payout ratio is presently 28.29%.

Institutional Investors Weigh In On Labcorp

Institutional investors and hedge funds have recently made changes to their positions in the stock. Harbor Asset Planning Inc. acquired a new position in shares of Labcorp in the 2nd quarter valued at $25,000. Caldwell Trust Co acquired a new position in shares of Labcorp in the second quarter valued at about $25,000. Financial Gravity Companies Inc. acquired a new stake in shares of Labcorp during the second quarter worth about $26,000. JPL Wealth Management LLC purchased a new stake in Labcorp in the third quarter valued at approximately $28,000. Finally, Motco purchased a new stake in Labcorp in the third quarter valued at approximately $32,000. 95.94% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Adam H. Schechter sold 5,745 shares of the stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $262.75, for a total value of $1,509,498.75. Following the sale, the chief executive officer owned 87,574 shares in the company, valued at $23,010,068.50. This represents a 6.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richelle P. Parham sold 7,009 shares of the firm’s stock in a transaction on Friday, October 31st. The stock was sold at an average price of $254.28, for a total transaction of $1,782,248.52. Following the transaction, the director directly owned 2,469 shares of the company’s stock, valued at approximately $627,817.32. This trade represents a 73.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.84% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Evercore ISI boosted their target price on shares of Labcorp from $300.00 to $305.00 and gave the stock an “outperform” rating in a report on Friday, October 3rd. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Labcorp in a research report on Wednesday, October 8th. Barclays boosted their price objective on shares of Labcorp from $275.00 to $290.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd. Truist Financial set a $320.00 target price on shares of Labcorp in a research note on Tuesday, October 14th. Finally, Mizuho lifted their price target on shares of Labcorp from $285.00 to $320.00 and gave the stock an “outperform” rating in a report on Friday, October 17th. Twelve equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Labcorp presently has a consensus rating of “Moderate Buy” and an average target price of $297.07.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About Labcorp

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.